Erratum: Bayesian clinical trial designs: Another option for trauma trials? (Journal of Trauma and Acute Care Surgery (2017) 83 (736-741) DOI: 10.1097/TA.0000000000001638);Bayesian clinical trial designs: Another option for trauma trials?

Journal of Trauma and Acute Care Surgery

Volumn 83, Issue 4, 2017, Pages 736-741

  Jansen, Jan O ^a   Pallmann, Philip ^b   Maclennan, Graeme ^a   Campbell, Marion K ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BALLOON OCCLUSION; BAYES THEOREM; BLEEDING; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; EARLY TERMINATION OF CLINICAL TRIAL; ENDOVASCULAR SURGERY; HUMAN; INJURY; KNOWLEDGE; MORTALITY; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; STUDY DESIGN; SURVIVAL; TRUNK; MEDICAL RESEARCH; METHODOLOGY; TRAUMATOLOGY;

BAYES THEOREM; BIOMEDICAL RESEARCH; HUMANS; RESEARCH DESIGN; TRAUMATOLOGY;

EID: 85023173616     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000002236     Document Type: Erratum

References (22)

1. Brenner ML, Moore LJ, DuBose JJ, Tyson GH, McNutt MK, Albarado RP, Holcomb JB, Scalea TM, Rasmussen TE. A clinical series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and resuscitation. J Trauma Acute Care Surg. 2013;75(3):506-511.
2. DuBose JJ, Scalea TM, Brenner M, Skiada D, Inaba K, Cannon J, Moore L, Holcomb J, Turay D, Arbabi CN, et al. The AAST Prospective Aortic Occlusion for Resuscitation in Trauma and Acute Care Surgery (AORTA) Registry: data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J Trauma Acute Care Surg. 2016;81(3):409-419.
3. Abe T, UchidaM, Nagata I, Saitoh D, Tamiya N. Resuscitative endovascular balloon occlusion of the aorta versus aortic cross clamping among patients with critical trauma: A nationwide cohort study in Japan. Crit Care. 2016; 20(1):400.
4. Norii T, Miyata S, Terasaka Y, Guliani S, Lu SW, Crandall C. Resuscitative endovascular balloon occlusion of the aorta in trauma patients in youth. J Trauma Acute Care Surg. 2017;82(5):915-920.
5. Moore LJ, Brenner M, Kozar RA, Pasley J, Wade CE, Baraniuk MS, Scalea T, Holcomb JB. Implementation of resuscitative endovascular balloon occlusion of the aorta as an alternative to resuscitative thoracotomy for noncompressible truncal hemorrhage. J Trauma Acute Care Surg. 2015;79(4):523-530.
6. Norii T, Crandall C, Terasaka Y. Survival of severe blunt trauma patients treated with resuscitative endovascular balloon occlusion of the aorta compared with propensity score-adjusted untreated patients. J Trauma Acute Care Surg. 2015;78(4):721-728.
7. Barnard EB, Morrison JJ, Madureira RM, Lendrum R, Fragoso-Iñiguez M, Edwards A, Lecky F, Bouamra O, Lawrence T, Jansen JO. Resuscitative endovascular balloon occlusion of the aorta (REBOA): A population based gap analysis of trauma patients in England and Wales. Emerg Med J. 2015; 32(12):926-932.
8. Parmar MK, Sydes MR, Morris TP. How do you design randomised trials for smaller populations? A framework. BMC Med. 2016;14(1):183.
9. Flight L, Julious SA, Goodacre S. Can emergency medicine research benefit from adaptive design clinical trials? Emerg Med J. 2017;34(4):243-248.
10. Lewis RJ, Bessen HA. Sequential clinical trials in emergency medicine. Ann Emerg Med. 1989;18(4):438.
11. Jennison C, Turnbull BW. Group Sequential Methods With Applications to Clinical Trials. London CRC Press; 1999.
12. Whitehead J. The Design and Analysis of Sequential Clinical Trials. Chichester John Wiley & Sons; 1997.
13. Hampson LV, Whitehead J, Eleftheriou D, Brogan P. Bayesian methods for the design and interpretation of clinical trials in very rare diseases. Stat Med. 2014;33(24):4186-4201.
14. Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, Altman DG. Statistical tests, P values, confidence intervals, and power: A guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337-350.
15. Glaser DN. The controversy of significance testing: misconceptions and alternatives. Am J Crit Care. 1999;8(5):291-296.
16. Morey RD, Hoekstra R, Rouder JN, Lee MD,Wagenmakers EJ. The fallacy of placing confidence in confidence intervals. Psychon Bull Rev. 2016;23(1): 103-123.
17. Gsponer T, Gerber F, Bornkamp B, Ohlssen D, Vandemeulebroecke M, Schmidli H. A practical guide to Bayesian group sequential designs. Pharm Stat. 2014;13(1):71-80.
18. Gerber F, Gsponer T. gsbDesign: an R Package for evaluating the operating characteristics of a group sequential Bayesian design. J Stat Soft. 2016;69(11).
19. Sutton AJ, Abrams KR. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res. 2001;10(4):277-303.
20. European Medicines Agency. Guideline on Clinical Trials in Small Populations. London: EMA; 2006.
21. Food and Drug Administration. Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. FDA; 2010.
22. Buxton MJ. Problems in the economic appraisal of new health technology: The evaluation of heart transplants in the UK. In: Drummond MF, ed. Economic Appraisal of Health Technology in the European Community. Oxford: Oxford Medical Publications; 1987:103-118.